Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs
Author:
Publisher
Springer Science and Business Media LLC
Subject
Otorhinolaryngology
Link
http://link.springer.com/content/pdf/10.1007/s00106-014-2927-0.pdf
Reference15 articles.
1. Chawla A, Adkins D, Worden FP et al (2014) Effect of the addition of temsirolimus to cetuximab in cetuximab-resistant head and neck cancers: results of the randomized PII MAESTRO study. ASCO Meeting Abstracts 32:6089. http://meetinglibrary.asco.org/. Zugegriffen: 26. Aug. 2014
2. Escudier B, Michaelson MD, Motzer RJ et al (2014) Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. Br J Cancer 110:2821–2828
3. Fayette J, Guigay J, Le Tourneau C et al (2014) Cabazitaxel in patients with refractory recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): results of phase II trial unicancer ORL03. ASCO Meeting Abstracts 32:e17028. http://meetinglibrary.asco.org/. Zugegriffen: 26. Aug. 2014
4. Fury MG, Sherman E, Ho A et al (2012) A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC). Cancer Chemother Pharmacol 70:121–128
5. Fury MG, Xiao H, Baxi SS et al (2014) A phase II trial of temsirolimus plus low-dose weekly carboplatin and paclitaxel for recurrent/metastatic HNSCC. ASCO Meeting Abstracts 32:6019. http://meetinglibrary.asco.org/. Zugegriffen: 26. Aug. 2014
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Head and neck cancer patient journey’s health literacy: a multidisciplinary team perspective. VOICE study;Supportive Care in Cancer;2024-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3